These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 18701082)
1. Structures of the toll-like receptor family and its ligand complexes. Jin MS; Lee JO Immunity; 2008 Aug; 29(2):182-91. PubMed ID: 18701082 [TBL] [Abstract][Full Text] [Related]
2. Structures of TLR-ligand complexes. Jin MS; Lee JO Curr Opin Immunol; 2008 Aug; 20(4):414-9. PubMed ID: 18585456 [TBL] [Abstract][Full Text] [Related]
3. Two modes of ligand recognition by TLRs. Brodsky I; Medzhitov R Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640 [TBL] [Abstract][Full Text] [Related]
4. Sensing of microbial molecular patterns by Toll-like receptors. Song DH; Lee JO Immunol Rev; 2012 Nov; 250(1):216-29. PubMed ID: 23046132 [TBL] [Abstract][Full Text] [Related]
5. Roles for accessory molecules in microbial recognition by Toll-like receptors. Miyake K J Endotoxin Res; 2006; 12(4):195-204. PubMed ID: 16953972 [TBL] [Abstract][Full Text] [Related]
6. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Carpenter S; O'Neill LA Biochem J; 2009 Jul; 422(1):1-10. PubMed ID: 19627256 [TBL] [Abstract][Full Text] [Related]
7. Structural biology of the Toll-like receptor family. Kang JY; Lee JO Annu Rev Biochem; 2011; 80():917-41. PubMed ID: 21548780 [TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Jin MS; Kim SE; Heo JY; Lee ME; Kim HM; Paik SG; Lee H; Lee JO Cell; 2007 Sep; 130(6):1071-82. PubMed ID: 17889651 [TBL] [Abstract][Full Text] [Related]
10. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Kang JY; Nan X; Jin MS; Youn SJ; Ryu YH; Mah S; Han SH; Lee H; Paik SG; Lee JO Immunity; 2009 Dec; 31(6):873-84. PubMed ID: 19931471 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912 [TBL] [Abstract][Full Text] [Related]
15. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Shibolet O; Podolsky DK Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1469-73. PubMed ID: 17554134 [TBL] [Abstract][Full Text] [Related]
16. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456 [TBL] [Abstract][Full Text] [Related]
17. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480 [TBL] [Abstract][Full Text] [Related]
18. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Nakata T; Yasuda M; Fujita M; Kataoka H; Kiura K; Sano H; Shibata K Cell Microbiol; 2006 Dec; 8(12):1899-909. PubMed ID: 16848791 [TBL] [Abstract][Full Text] [Related]
19. LPS, TLR4 and infectious disease diversity. Miller SI; Ernst RK; Bader MW Nat Rev Microbiol; 2005 Jan; 3(1):36-46. PubMed ID: 15608698 [TBL] [Abstract][Full Text] [Related]
20. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Bérubé J; Bourdon C; Yao Y; Rousseau S Cell Signal; 2009 Mar; 21(3):448-56. PubMed ID: 19121387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]